[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
NCT00556153 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-01-08
Summary
The first phase of the study will investigate if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue.
Conditions
Interventions
- DRUG
-
[F-18]Fluoro-DOPA PET, a diagnostic radiopharmaceutical
A single dosage of the diagnostic drug will be administered to individuals who meet inclusion criteria after informed consent.
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Michael J Gelfand, M.D. · Cincinnati Children's Hospital, Cincinnati, OH
Eligibility
- Min Age
- 5 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Completion
- 2013-02-28
More Related Trials
-
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
NCT03451123 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity
NCT00067821 ·Status: COMPLETED
-
18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms
NCT03121599 ·Status: TERMINATED ·Phase: NA
-
18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma
NCT05826158 ·Status: RECRUITING ·Phase: NA
-
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
NCT01999270 ·Status: COMPLETED ·Phase: PHASE1
-
F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
NCT00180193 ·Status: TERMINATED
-
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
NCT02104310 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors
NCT03905538 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
18F-FDOPA PET in Neuroendocrine Tumours
NCT02431715 ·Status: NO_LONGER_AVAILABLE
-
Multi-Tracer PET Assessment of Primary Brain Tumors
NCT00813566 ·Status: COMPLETED ·Phase: PHASE1
-
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
NCT00832598 ·Status: COMPLETED ·Phase: NA
-
[18F]FPIA PET/CT Imaging in Patients With Solid Tumours
NCT04717674 ·Status: RECRUITING ·Phase: PHASE2
-
Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
NCT07110519 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
NCT02919332 ·Status: WITHDRAWN
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
Normal Variants and Pitfalls of 18F_FDG PET/CT in Pediatric Oncology
NCT06612567 ·Status: NOT_YET_RECRUITING
-
Molecular Pituitary Imaging Using 18F-FET PET
NCT06584123 ·Status: RECRUITING ·Phase: NA
-
F-Tryptophan PET/CT in Human Cancers
NCT05556473 ·Status: RECRUITING ·Phase: PHASE1
-
11C Topotecan PET Imaging
NCT00253461 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Phase I, Open Label, Single Center Safety Study of [F-18]FLT
NCT00553748 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
NCT00850278 ·Status: COMPLETED ·Phase: NA
-
The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents
NCT03402425 ·Status: UNKNOWN ·Phase: NA
-
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
NCT06667726 ·Status: RECRUITING ·Phase: PHASE2
-
[18F]Fluciclatide PET Imaging of Pazopanib Response
NCT01961583 ·Status: TERMINATED ·Phase: PHASE2